Ambiq Micro earnings release, August 11, 2026

Ambiq Micro, Inc. (AMBQ) · Form 8-K, Item 2.02 · Filed · SEC filing

Ambiq Reports Second Quarter 2026 Financial Results

Delivered record quarterly net sales, increasing approximately 90% year-over-year, driven by strong demand for edge AI solutions

Gross profit more than doubled year-over-year on higher net sales and margin expansion

Expect third quarter net sales of $36.0 million to $37.0 million, which would represent the sixth consecutive quarter of sequential growth

AUSTIN, Texas, August 11, 2026 — Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for the second quarter 2026.

Second Quarter 2026 and Recent Highlights

• Delivered strong net sales on growing edge AI demand momentum:

Net sales increased approximately 90%, year-over-year, driven by accelerating edge AI demand across customers, end markets and products.

• Gross profit outpaced net sales growth:

GAAP gross profit increased approximately 113% and non-GAAP gross profit increased approximately 109% year-over-year, with GAAP gross margin and non-GAAP gross margin expanding by 490 basis points and 450 basis points respectively.

• Enhanced financial flexibility to capitalize on growth opportunities ahead:

Completed an upsized public offering in June, raising approximately $168 million in net proceeds.

• Expanded edge AI software stack

: Launched heliaCORE and compressionKIT to accelerate customers' deployment of small footprint and energy efficient AI models on the Apollo SoC families. We also announced heliaPROFILER, a new open-source profiling tool that speeds customers' AI model development.

• Strengthened global capital markets access:

Announced a dual listing on the Singapore Exchange Main Board under ticker AMQ, expanding investor reach across Asia and reinforcing our long-term growth strategy in the global semiconductor market.

Management Commentary

“Since the start of the year, we have seen a step-change in demand, further reinforcing our belief in the scale and durability of the edge AI opportunity. That momentum drove our net sales up approximately 90% year over year, marking our fifth consecutive quarter of growth, and we expect demand to strengthen even further in the second half of the year,” said Fumihide Esaka, CEO of Ambiq. “Given the rapid acceleration in AI demand, we and the broader semiconductor industry are facing supply constraints. Even with this, we are on pace to more than double net sales in the second half of 2026 compared to last year. We are acting decisively to expand capacity, support our customers and capture the full opportunity we see to enable the next generation of intelligent edge products."

Summary of Second Quarter 2026 Results

*Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expense and non-GAAP net loss are non-GAAP financial measures. See "Non-GAAP Financial Measures" below for definitions of each of these measures, and the tables accompanying this press release for reconciliations of these measures to their most comparable GAAP measure.

Third Quarter Business Outlook¹

Ambiq’s current expectations for the quarter ending September 30, 2026, include the following:

• Net sales within a range of $36.0 million to $37.0 million, reflecting accelerating demand for edge AI, partially constrained by industry-wide supply availability

• Non-GAAP gross margin between 46.5% and 47.5%, driven by favorable mix and manufacturing efficiencies

• Non-GAAP operating expense of $24.0 million to $25.0 million, reflecting investments to support product development and our strategic growth priorities, including planned intellectual property investments

• Non-GAAP net loss per share within a range of ($0.20) to ($0.12) based on a weighted average share count of 24.17 million shares outstanding¹

Financial statements

Income Statement

Three months ended June 30, — Summary of Second Quarter 2026 Results (in thousands)

Three months ended June 30, – 2026Three months ended March 31, – 2026Three months ended June 30, – 2025Quarter over quarter changeYear over year change
Net sales33,90125,06017,87335.3%89.7%
Gross profit15,26710,8917,17040.2%112.9%
Gross margin45.0%43.5%40.1%
Operating expense23,99422,58015,9676.3%50.3%
Net loss-7,115-10,171-8,4963,0561,381

Income Statement

Three months ended June 30, — Summary of Second Quarter 2026 Results (in thousands)

Three months ended June 30, – 2026Three months ended March 31, – 2026Three months ended June 30, – 2025Quarter over quarter changeYear over year change
Non-GAAP Gross profit15,98911,5777,64038.1%109.3%
Non-GAAP Gross margin47.2%46.2%42.7%
Non-GAAP Operating expense19,37418,14413,8196.8%40.2%
Non-GAAP Net loss-1,772-5,046-5,8623,2744,090

Income Statement

Three months ended — (in thousands, except share and per share amounts)

Three months ended – June 30, 2026Three months ended – June 30, 2025Six months ended – June 30, 2026Six months ended – June 30, 2025
Net sales33,90117,87358,96133,605
Cost of sales18,63410,70332,80318,046
Gross profit15,2677,17026,15815,559
Operating expenses:Research and development14,1398,89826,97117,585
Operating expenses:Selling, general and administrative9,8557,06919,60315,512
Operating expenses:Total operating expenses23,99415,96746,57433,097
Operating expenses:Loss from operations-8,727-8,797-20,416-17,538
Operating expenses:Other income, net1,6133153,134776
Operating expenses:Loss before income taxes-7,114-8,482-17,282-16,762
Operating expenses:Provision for income taxes114418
Operating expenses:Net loss-7,115-8,496-17,286-16,780
Operating expenses:Net loss per share, basic and diluted-0.32-18.89-0.82-37.59
Operating expenses:Weighted-average shares used in computing net loss per share, basic and diluted21,742,929449,78521,073,361446,390
Comprehensive loss:Currency translation adjustment12411018980
Comprehensive loss:Comprehensive loss-6,991-8,386-17,097-16,700

Income Statement

Three months ended June 30, — Non-GAAP Gross Profit and Non-GAAP Gross Margin: (in thousands)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025Three months ended March 31, – 2026
Gross profit15,2677,17026,15815,55910,891
Add:Depreciation and amortization5044301,003992499
Add:Stock-based compensation21840405100187
Add:Gain on nonmonetary transaction-1,600
Add:Non-GAAP gross profit15,9897,64027,56615,05111,577

Income Statement

Three months ended June 30, — Non-GAAP Operating Expenses: (in thousands)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025Three months ended March 31, – 2026
Operating expenses9,8557,06919,60315,5129,748
Less:Depreciation and amortization37337617539
Less:Stock-based compensation1,6083973,2657981,657
Less:IPO and other transaction costs1,793
Less:Non-GAAP selling, general, and administrative expenses8,2106,63916,26212,7468,052

Income Statement

Three months ended June 30, — Non-GAAP Net Loss per Share: (in thousands, except share and per share amounts)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
GAAP net loss-7,115-8,496-17,286-16,780
Weighted-average shares used in computing GAAP net loss per share21,742,929449,78521,073,361446,390
GAAP net loss per share-0.32-18.89-0.82-37.59
Non-GAAP net loss-1,772-5,862-6,818-11,079
Weighted-average shares used in computing non-GAAP net loss per share21,742,929449,78521,073,361446,390
Non-GAAP net loss per share-0.07-13.03-0.32-24.82

Balance Sheet

December 31, — (in thousands, except share and per share amounts)

June 30, – 2026December 31, – 2025
Current assets:Cash and cash equivalents366,774140,275
Current assets:Accounts receivable, net17,5287,286
Current assets:Inventories29,36516,937
Current assets:Prepaid expenses and other current assets2,9583,421
Current assets:Total current assets416,625167,919
Current assets:Property, equipment and software, net of accumulated depreciation and amortization of $15,480 and $14,632, respectively4,3284,137
Current assets:Right-of-use assets, net3,244638
Current assets:Intangible assets, net of accumulated amortization of $13,469 and $10,752, respectively10,22411,593
Current assets:Other assets1,201393
Current assets:Total assets435,622184,680
Current liabilities:Accounts payable10,6158,577
Current liabilities:Accrued and other current liabilities14,46910,201
Current liabilities:Short-term lease liabilities1,034400
Current liabilities:Total current liabilities26,11819,178
Current liabilities:Long-term lease liabilities3,549278
Current liabilities:Other long-term liabilities1,2832,765
Current liabilities:Total liabilities30,95022,221

Cash Flow

For the six months ended June 30, — (in thousands)

For the six months ended June 30, – 2026For the six months ended June 30, – 2025
Cash flows from operating activitiesNet loss-17,286-16,780
Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization3,5253,814
Adjustments to reconcile net loss to net cash used in operating activities:Stock-based compensation6,9191,616
Adjustments to reconcile net loss to net cash used in operating activities:Gain on receipt of nonmonetary tangible assets-1,600
Adjustments to reconcile net loss to net cash used in operating activities:Change in right-of-use assets386510
Adjustments to reconcile net loss to net cash used in operating activities:Change in warrant valuations and cancellations60
Adjustments to reconcile net loss to net cash used in operating activities:Other-110
Changes in operating assets and liabilitiesAccounts receivable-10,2422,705
Changes in operating assets and liabilitiesInventories-12,428-751
Changes in operating assets and liabilitiesPrepaid expenses and other assets931-1,257
Changes in operating assets and liabilitiesOther long-term assets49-1
Changes in operating assets and liabilitiesAccounts payable4,002874
Changes in operating assets and liabilitiesAccrued and other current liabilities3,872446
Changes in operating assets and liabilitiesOther long-term liabilities-406-75
Changes in operating assets and liabilitiesNet cash used in operating activities-20,678-10,549
Cash flows from investing activitiesPurchase of intangible assets-5,120-2,687
Cash flows from investing activitiesPurchases of property, equipment and software-781-454
Cash flows from investing activitiesNet cash used in investing activities-5,901-3,141
Cash flows from financing activitiesProceeds from issuance of common stock in connection with follow-on offerings, net of underwriting discounts and commissions245,468
Cash flows from financing activitiesPayment of deferred offering costs-1,542
Cash flows from financing activitiesProceeds from exercise of stock options6,099175
Cash flows from financing activitiesProceeds from exercise of warrants3,010
Cash flows from financing activitiesNet cash provided by financing activities253,035175
Cash flows from financing activitiesEffect of exchange rate changes on cash and cash equivalents4339
Cash flows from financing activitiesNet increase (decrease) in cash and cash equivalents226,499-13,476
Cash flows from financing activitiesCash and cash equivalents at beginning of period140,27560,981
Cash flows from financing activitiesCash and cash equivalents at end of period366,77447,505
Supplemental disclosure of non-cash investing and financing activitiesIntangible assets in accounts payable, accrued and other long-term liabilities5,9918,328
Supplemental disclosure of non-cash investing and financing activitiesGain on receipt of nonmonetary tangible assets1,600
Supplemental disclosure of non-cash investing and financing activitiesRight-of-use assets obtained in exchange for new operating lease liabilities3,018383
Full release

Ambiq's financial outlook is based on assumptions that it believes to be reasonable as of the date of this release, but may be materially affected by many factors, as discussed below in "Forward-Looking Statements." Actual results may vary from the guidance and the variations may be material. We undertake no intent or obligation to publicly update or revise this outlook, whether as a result of new information, future events or otherwise, except as required by law. The Company is unable to include a reconciliation of forward-looking non-GAAP net loss per share, non-GAAP gross margin and non-GAAP operating expense to the most directly comparable GAAP measure without unreasonable effort due to the high variability with respect to the impact of items such as depreciation and amortization and, stock-based compensation expense and other items that are excluded from these non-GAAP measures.

Conference Call

Ambiq will host a conference call for analysts and investors today at 8:30 a.m. Eastern Time. Interested participants can access the call by dialing 1-833-461-5787 and providing conference ID 195766563. International callers may join the call by dialing +1-585-542-9983, using the same code. The call will also be available as a live and archived webcast on the Events & Presentations section of Ambiq's Investor Relations website.

About Ambiq Micro

Ambiq’s mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Built on its patented Subthreshold Power Optimized Technology (SPOT®) and the HELIA™ AI platform, Ambiq empowers manufacturers to bring more capable AI to the edge, where power, memory, and energy efficiency are most critical. Ambiq enables more intelligent, always-on edge devices across healthcare, wearables, industrial automation, smart environments, and other emerging AI applications. With more than 300 million devices shipped worldwide, Ambiq continues to shape the future of always-on Edge AI. Headquartered in Austin, Texas, Ambiq serves customers globally. For more information, visit www.ambiq.com.... (tP Financial Measures

Ambiq supplements its reporting of financial information determined under generally accepted accounting principles in the United States of America (GAAP), including the use of non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP R&D expenses, non-GAAP SG&A expenses and non-GAAP net loss. These non-GAAP financial measures help management make strategic decisions, establish budgets and operational goals for managing the business, analyzing financial results, and evaluating business performance. Ambiq defines non-GAAP gross profit as gross profit adjusted to exclude expenses not directly attributable to gross profit, such as depreciation and amortization, stock-based compensation and gain on nonmonetary transactions. Ambiq defines non-GAAP gross margin as non-GAAP gross profit as a percentage of net sales. Ambiq defines non-GAAP operating expenses, non-GAAP R&D expenses and non-GAAP SG&A expenses as operating expenses, R&D expenses and SG&A expenses, as applicable, adjusted to exclude expenses not directly attributable to operating expenses, R&D expenses and SG&A expenses, as applicable, such as depreciation and amortization, stock-based compensation, severance costs, and IPO and other transaction costs, as applicable. Ambiq defines non-GAAP net loss as net loss adjusted to exclude expenses not directly attributable to the performance of operations, such as income taxes, depreciation and amortization, stock-based compensation, gain on nonmonetary transactions, severance costs, IPO and other transaction costs and warrant valuation.

Ambiq believes these non-GAAP financial measures provide additional tools for investors to use in comparing core business and results of operations over multiple periods with other companies in the industry, many of which present similar non-GAAP financial measures. However, Ambiq's presentation of non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP R&D expenses, non-GAAP SG&A expenses, and non-GAAP net loss may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures are calculated. These non-GAAP measures have limitations, and should not be considered as the sole measures of our performance and should not be considered in isolation from, or as a substitute for, the most comparable measure calculated in accordance with GAAP.

Forward-Looking Statements

The statements contained in this press release that are not historical facts are forward-looking statements. You can identify forward-looking statements because they contain words such as "believes," "expects," "may," "will," "should," "seeks," "intends," "plans," "estimates," or "anticipates," or similar expressions which concern our strategy, plans, projections or intentions. These forward-looking statements may be included throughout this press release, and include, but are not limited to, statements relating to Ambiq's expectations around its strategic initiatives, growth trajectory and expected third quarter business outlook. By their nature, forward-looking statements are not statements of historical fact or guarantees of future performance and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify including those described in the section titled "Risk Factors" in Ambiq's Annual Report on 10-K for the year ended December 31, 2025, as well as in other filings Ambiq may make with the SEC in the future. Ambiq's expectations, beliefs and projections are expressed in good faith and Ambiq believes there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date of this release. Ambiq undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

Availability of Information on Our Website

We routinely use our investor relations website (ir.ambiq.com) to post presentations to investors and other important information, including information that may be material. Accordingly, we encourage investors and others interested in Ambiq to review the information it makes public on its investor relations website.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Ambiq Micro earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.